DEVELOPMENT AND EVALUATION OF CIPROFLOXACIN HYDROCHLORIDE LOADED OCULAR INSERT BY USING PLANTAGO OVATA†AS NATURAL POLYMER
DOI:
https://doi.org/10.22159/ijcpr.2018v10i4.28474Keywords:
Ciprofloxacin Hydrochloride, HPMC, Plantago Ovata, Occular insertAbstract
Objective: The present work focus in the direction of Development and evaluation of Ciprofloxacin Hydrochloride loaded ocular insert by using plantago ovata†as natural polymerâ€. The current work was carried out to evaluate the control release profile of ocular insert. Natural polymer in ocular insert was used for studying the long acting property. Natural polymer is also used to enhance the bioavailability of drug and reduce toxicity. It is also used to increase the duration of action of drug for prolongs action and gives better in vitro performance as compare than to the conventional ocular formulation.
Methods: Solvent casting method was used in the formulation of Ciprofloxacin Hydrochloride loaded ocular inserts. Different ocular insert formulations of varying polymer concentration were prepared. Ocular insert formulation H-1 to H-3 was prepared by using different concentration of HPMC and formulation P-1 to P-4 was prepared by using different concentration of Plantago Ovata.
Results: The ocular inserts formulation was within the acceptable limits. All the pre formulation parameters of polymers such as derived properties, compressibility index, Hausner's ratio, viscosity, melting point, swelling ratio, loss on drying, PH of mucilage solution and pre formulation of active pharmaceutical ingredient such as estimation of drug by using UV spectroscopy, determination of melting point, solubility, partition coefficient and FTIR for compatibility study of drug and excipient were evaluation. FTIR analysis also confirmed no drug-excipient interaction.
Conclusion: Prepared inserts in the present study were semitransparent. The mixing of the drug in to the polymer is uniform, due to this; the drug content of all formulation is good. Formulation P4 was selected because it showed better release profile, drug content and other physicochemical properties than other formulated batch when compare. All the prepared inserts showed in vitro drug release for the period of 4 h as compare to the marketed formulation. An in vitro drug release study revealed that ocular formulation gives a prolong action. The formulation was found to be long acting.Downloads
References
Bruck Sd. Controlled drug delivery. Bocaraton, Florida: Crc Press; 1983.
Baeyens V, O Felt-Baeyens, S Rougier, S Pheulpin, B Boisrame, R Gurny. Clinical evaluation of bioadhesive ophthalmic drug inserts (Bodi®) for the treatment of external ocular infections in dogs. J Controlled Release 2002;85:163-8.
Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol 2013;2:47-64.
Bower KS, RP Kowalski, YJ Gordon. Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol 1996;121:712.
Shanmugam S, Manavalan R, Venkappayya D, Sundaramoorthy K, Mounnissamy V M, Hemalatha, et al. Natural polymers and thire application. Indian J Nat Prod Resour 2005;4:478-81.
Abadia AR, Aramayona JJ, Munoz MJ. Ciprofloxacin phar-macokinetics in dogs following oral administration. Zentralbl Veterinarmed A 1995;42:505–11.
Kulkarni GT, Gowthamarajan K, Rao BG, Suresh B. Evaluation of binding properties of Plantago Ovata and Gonella Foenumgraecum mucilage. Indian Drugs 2002;39:422-5.
Kulkarni GT, Gowthamarajan K, Rao BG, Suresh B. Evaluation of binding properties of selected natural mucilage. J Sci Industrial Res 2002;61:529-32.
Tahir MA, Awadhesh K, Swati S, Sant S, Sajid MA, Pattnaik GD, et al. Optimization of fast disintegrating tablets for diclofenac sodium using isabgol mucilage as super disintegrant. Int J Pharm Sci 2010;2:496-501.
Mehta DM, Shelat PK, Parejiya PB, Patel AJ, Barot B. Investigation of Plantago Ovata husk as a disintragation agent for development of famotidin tablets. Int J Pharm Sci Nanotechnol 2011;4:1412-7.
Http://Www.Ijpcbs.Com/Files/08-209.Pdf. [Last accessed on 10 Mar 2018]
Sucheta B, Jarande K, Patil M, Patanakar RD. Isolation and evaluation of natural superdisintegrant from Plantago Ovata in mdts of telmisartan. J Pharm Cosmetol 2012;2:9-21.
Safila Naveed. Simple UV spectrophotometric assay of atorvastatin API formulation and their comparative study. Global J Med Res 2014;14:35-8.
Malviya R. Extraction characterization and evaluation of selected mucilage as pharmaceutical excipient. Pharm Excipient 2011;41:39-44.
Gevariya H, Patel JK. Long acting betaxolol ocular inserts based on polymer composite. Curr Drug Delivery 2013;10:1-10.
http://Www.Chem.Ucalgary.Ca/Courses/351/laboratory/Meltingpoint.Pdf. [Last accessed on 10 Mar 2018]
Ghelani TK, Seth AK, Saini V, Singhal S, Kumar S, Yadav YC. Formulation and evaluation of timolol maleate ocular insert. Asian J Biochem 2011;1:166-74.
Manjunatha KM, Kulkarni GT. Design, development and evaluation of controlled release levobunolol hydrochloride ocular inserts for glaucoma therapy. J Chronother Drug Delivery 2012;3:87-97.
Aburahma MH, Mahmoud A. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation. Am Assoc Pharm Sci Technol 2011;12:1335-47.
Shivhare UD, Chavan MA, Bhusari KP, Mathur VB, Kakade VN. Formulation development and evaluation of controlled release ocular insert. Int J Biol Pharm Res 2012;3:66-74.
Manjunatha KN, Kulkarni GT, Ismail Md. Design and optimization of controlled release ocular inserts of dorzolamide hydrochloride and timolol maleate for treatment of glaucoma. Int General Pharm Sci Res 2012;3:3915-22.
Aher ND. Nair HA. Bilayered films based on novel polymer derivative for improved ocular therapy of gatifloxacin. Sci World J 2014:1-9. http://dx.doi.org/10.1155/2014/297603
Singh V, Bushetti SS, Appala R, Ahmed R, Singh M, Ajmal M. Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate. J Pharm Bioallied Sci 2011;3:1/9-9/9.
Sachdeva D, Bhandari A. Design, formulation, evaluation of levobunolol hcl ocular inserts. J Pharm Sci Res 2011;3:1625-31.
Gevariya H, Patel JK. Long acting betaxolol ocular inserts based on polymer composite. Curr Drug Delivery 2013;10:1-10.
Nair RV, Nair SC, Anoop KR. Ocular insert of timolol maleate using naturally occurring biodegradable polymer. J Chem Pharm Res 2015;7:476-85.
Indian Pharmacopoeia 2010. New Delhi: Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Govt. of India; 2007. p. 52-9.
Khokhar P. Design and characterisation of chloramphenicol ocular insert for ocular drugdelivery. Int J Pharma Res Rev 2015;4:9-15.
Published
How to Cite
Issue
Section
